OBJECTIVE: The aim of continuous subcutaneous insulin infusion (CSII) therapy in patients with type 1 diabetes mellitus (T1DM) is to mimic as closely as possible the normal physiologic pattern seen in individuals without diabetes. This study was undertake
Continuous glucose monitoring in children with type 1 diabetes: before and after insulin pump therapy.All Scholarly Works
Document TypeArticle, Peer-reviewed
Citation InformationPediatr Diabetes 2004 Mar;5(1):10-5.